HotOtc Featured Company: Synthetic Blood International Inc. (SYBD.OB) Readies for Phase IIb Synthetic Blood Trials after Defense Department Grant
Finding a substitute for blood has been a goal of medical researchers for a very long time. Unfortunately, it always seemed to be just out of the reach of researchers. Today, however, the goal has been rethought and, with a different paradigm, close to a real possibility. Synthetic Blood International Inc., a biomedical development company, works to develop oxygen carrying fluid exchange products. Among other areas, the company is currently working toward products oriented toward diabetes, oxygen substitutes, synthetic blood and malignant tumors. Currently, serious discussions are ongoing with large pharmaceutical companies for distribution upon development success and regulatory approval.…